Zilapro Powder for Suspension

Cefprozil
250mg/5ml
Beximco Pharmaceuticals Ltd.
Pack size 56ml bot
Dispensing mode
Source
Agent
Retail Price 276 AED

Indications

Zilapro Powder for Suspension is used for: Pharyngitis, Susceptible infections, Sinusitis, Otitis media, Skin and skin structure infections, Tonsillitis, Respiratory tract infections, Acute Maxillary Sinusitis, Acute bacterial exacerbation of chronic bronchitis

Adult Dose

Pharyngitis & Tonsillitis 500 mg PO once daily for 10 days Respiratory Tract Infections, Skin Infections 250-500 mg twice daily OR 500 mg once daily for10 days

Child Dose

Child: PO 15–30 mg/kg/day q12h Acute Otitis Media 6 months old-12 years old: 30 mg/kg/day divided q12hr PO x 10 days Acute Sinusitis 6 months old-12 years old: 15-30 mg/kg/day divided q12hr PO x10 days Pharyngitis & Tonsillitis 2-12 years old: 15 mg/kg/day divided q12hr PO x10 days Skin Infections 2-12 years old: 20 mg/kg PO qDay x10 days >12 years Pharyngitis & Tonsillitis 500 mg PO once daily for 10 days Respiratory Tract Infections, Skin Infections 250-500 mg twice daily OR 500 mg once daily for10 days

Renal Dose

Renal impairment: CrCl (ml/min) <30 Half normal dose.

Administration

May be taken with or without food. May be taken w/ meals to reduce GI discomfort.

Contra Indications

Hypersensitivity.

Precautions

Oral suspension contains aspartame; not indicated for patients with phenylketonuria Careful inquiry should be made to determine if patient has had previous hypersensitivity to cephalosporins, penicillins or similar drugs; cross sensitivity reported among beta-lactam antibiotics; discontinue therapy if reaction occurs Hypersensitivity reactions may require treatment with epinephrine and emergency measures, including intravenous fluids, oxygen, corticosteroids, intravenous antihistamines, pressor amines, and airway management as indicated Prescribing antibiotics in the absence of proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to patient and increases risk of development of drug-resistant bacteria Prolonged use of therapy may result in overgrowth of nonsusceptible organisms; careful observation of patient essential; if superinfection occurs during therapy, appropriate measures should be taken Cefprozil should be prescribed with caution in individuals with a history of gastrointestinal disease particularly colitis Positive direct Coombs’ tests have been reported during treatment with cephalosporin antibiotics. Monitor renal and haematologic status.

Pregnancy-Lactation

Pregnancy Category: B Lactation: low distribution into breast milk; use with caution

Interactions

Renal excretion delayed by probenecid. Decreases contraceptive effect of oestrogen-containing oral contraceptives. Contraindicated (0) Serious (4) BCG vaccine live cholera vaccine microbiota oral typhoid vaccine live

Adverse Effects

Side effects of Cefprozil : 1-10% Nausea (3.5%),Diarrhea (2.9%),Elevated LFTs (2%),Diaper rash (1.5%),Abdominal pain (1%),Dizziness (1%),Vomiting (1%) <1% Eosinophilia,Superinfection,Vaginitis,Cholestatic jaundice,Elevated BUN & creatinine,Prolonged PT Potentially Fatal: Pseudomembranous colitis.

Mechanism of Action

Cefprozil inhibits cell wall synthesis and has activity against a broad range of gram-positive and gram-negative bacteria.

Note

Zilapro 250mg/5ml Powder for Suspension manufactured by Beximco Pharmaceuticals Ltd.. Its generic name is Cefprozil. Zilapro is availble in Bangladesh. Farmaco BD drug index information on Zilapro Powder for Suspension is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Cefprozil :